Ann: Remestemcel-L for COVID-19 MIS-C published in Pediatrics, page-96

  1. 8,130 Posts.
    lightbulb Created with Sketch. 1408
    I absolutely agree.

    Why weren't they compared to other children who were in similar situations. I'm guessing the population is quite small and variable as it's quite rare but no mention of the standard disease progression.

    Would they have died? Where that assumption from? People are making assumptions left right and centre and making investment decisions based on them.

    I'm merely pointing out these assumptions aren't valid.

    The clinical results may be impressive. Maybe they're not. Again, who knows man.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$2.23
Change
-0.180(7.47%)
Mkt cap ! $2.841B
Open High Low Value Volume
$2.33 $2.35 $2.15 $13.51M 5.995M

Buyers (Bids)

No. Vol. Price($)
19 20998 $2.23
 

Sellers (Offers)

Price($) Vol. No.
$2.24 13380 9
View Market Depth
Last trade - 11.05am 21/07/2025 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.